

BridgeBio

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Founding Year
2014
Headquarters
Palo Alto
,
United States
Sector(s)
No items found.
Funding State
Pre-Seed
Seed
Series A
Series B+
Exited
Total Funding Amount
$5,630.20M
Funds that Investested
Sequoia Capital
Helps the daring build legendary companies, from idea to IPO and beyond.
Pre-Seed
Seed
Series A
Series B+
View Profile
Investors that Investested
Roelof Botha
Partner, Sequoia Capital
Seed/Early-stage and growth investor. Looks for unconventional founders to add to his impressive investment portfolio. Invested in Youtube, Evernote, Tumblr, Instagram, MongoDB, 23&Me, etc.
Pre-Seed
Seed
Series A
Series B+
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets